NeoVolta CEO granted 1.88M stock options

NeoVolta Inc. director and CEO Henry Ardes Johnson reported two equity compensation changes.

Rhea-AI Filing Summary

NeoVolta Inc. director and CEO Henry Ardes Johnson reported two equity compensation changes. He disposed of 1,280,000 restricted stock units in a transaction coded as a disposition to the issuer, reducing his RSU balance to zero. He was also granted 1,880,166 employee stock options at an exercise price of $0.00 per share, leaving him with 1,880,166 options held directly. According to the disclosure, these options vest 25% on issuance and 25% on each of April 19, 2026, April 19, 2027, and April 19, 2028, subject to his continued service.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Johnson Henry Ardes

Role CEO & President

Type	Security	Shares	Price	Value
Disposition	Restricted Stock Units	1,280,000	$0.00	$0.00
Grant/Award	Employee Stock Option (Right to buy)	1,880,166	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 0 contracts (Direct); Employee Stock Option (Right to buy) — 1,880,166 contracts (Direct)

Footnotes (4)

1. F1. Each restricted stock unit represented a contingent right to receive one shares of Company common stock.
2. F2. The restricted stock units set forth in this table were scheduled to vest in four equal annual installments beginning on April 19, 2025, subject to the grantee's continued service to the Company on each vesting date.
3. F3. Issued in connection with the reporting person's employment with the Company.
4. F4. Employee Stock Options vest as follows: 25% on issuance and 25% on each of April 19, 2026; April 19, 2027; and April 19, 2028, subject to reporting person's continued service to the Company on each vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did NeoVolta (NEOV) report for its CEO?

NeoVolta reported that CEO Henry Ardes Johnson disposed of 1,280,000 restricted stock units back to the issuer and received a grant of 1,880,166 employee stock options. Both transactions involve derivative securities tied to NeoVolta common stock.

How many restricted stock units did the NeoVolta (NEOV) CEO dispose of?

The CEO disposed of 1,280,000 restricted stock units in a transaction coded as a disposition to the issuer. After this event, his reported holdings of restricted stock units were reduced to zero according to the filing’s transaction table.

What stock option grant did NeoVolta (NEOV) award to its CEO?

NeoVolta awarded CEO Henry Ardes Johnson 1,880,166 employee stock options with an exercise price of $0.00 per share. These options are held directly and represent a new derivative position in the company’s common stock for the executive.

What is the vesting schedule for the NeoVolta (NEOV) CEO’s new stock options?

The employee stock options vest 25% on issuance and 25% on each of April 19, 2026, April 19, 2027, and April 19, 2028. Vesting is conditioned on the reporting person’s continued service to NeoVolta on each vesting date.

How were the disposed NeoVolta (NEOV) restricted stock units originally structured?

Each restricted stock unit represented a contingent right to receive one share of NeoVolta common stock. They had been scheduled to vest in four equal annual installments beginning April 19, 2025, subject to continued service, before being disposed of to the issuer.

Is the NeoVolta (NEOV) CEO’s option grant related to his employment?

Yes. The filing specifies that the equity awards were issued in connection with the reporting person’s employment with NeoVolta. This indicates they are part of his compensation package rather than open-market share purchases or sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 05:23 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Johnson Henry Ardes

(Last) (First) (Middle)

C/O NEOVOLTA, INC.

12195 DEARBORN PLACE

(Street)

POWAY CA 92064

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NeoVolta Inc. [ NEOV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO & President

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/23/2026		D			1,280,000	(2)	(2)	Common Stock	1,280,000	(3)	0	D
Employee Stock Option (Right to buy)	$3.54	02/23/2026		A		1,880,166		02/23/2026(4)	02/23/2031	Common Stock	1,880,166	(3)	1,880,166	D

Explanation of Responses:

1. Each restricted stock unit represented a contingent right to receive one shares of Company common stock.

2. The restricted stock units set forth in this table were scheduled to vest in four equal annual installments beginning on April 19, 2025, subject to the grantee's continued service to the Company on each vesting date.

3. Issued in connection with the reporting person's employment with the Company.

4. Employee Stock Options vest as follows: 25% on issuance and 25% on each of April 19, 2026; April 19, 2027; and April 19, 2028, subject to reporting person's continued service to the Company on each vesting date.

	/s/ Ardes Johnson	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.